Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 14

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]

Authors Mahboub BH , Vats MG , Al Zaabi A, Iqbal MN , Safwat T, Al-Hurish F, Miravitlles M , Singh D, Asad K, Zeineldine S, Al Hajjaj MS

Received 13 November 2018

Accepted for publication 13 November 2018

Published 18 January 2019 Volume 2019:14 Pages 115—116

DOI https://doi.org/10.2147/COPD.S194431



Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS. Int J Chron Obstruct Pulmon Dis. 2017;12:2869–2890.

Page 2885, Disclosure, the text “The authors report no conflicts of interest in this work” should read “BHM has a pending patent for Samsum sublingual immunotherapy with the US Patent and Trademark Office. MM has received speaker fees from Boehringer Ingelheim, Chiesi, Cipla,
Menarini, Rovi, Bial, CSL Behring, Grifols and Novartis; consultancy fees from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma, CSL Behring, Laboratories Esteve, Mereo BioPharm, Verona Pharma, pH Pharma, Novartis and Grifols; and research grants from GlaxoSmithKline and Grifols. DS has received speaking/consultancy fees from Apellis, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, Glenmark, Merck, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Skyepharma, Therevance and Verona; and research grants from AstraZeneca, Boehringer Ingelheim, Chiesi, Glenmark, Merck, Mundipharma, Novartis, Pfizer, Pulmatrix, Teva, Therevance and Verona. The authors report no other conflicts of interest in this work”.

Read the original article

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.